OSUR
HEALTHCAREOraSure Technologies Inc
AI Insight
What's Moving OSUR Today?
No stock-specific AI insight has been generated for OSUR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.08$4.58
$4.24
Fundamentals
Market Cap$286M
P/E Ratio—
EPS$-1.05
Dividend Yield—
Dividend / Share—
ROE-21.2%
Profit Margin-66.4%
Debt / Equity—
Trading
Volume564K
Avg Volume (10D)—
Shares Outstanding68.8M
OSUR News
22 articles- OraSure receives FDA clearance for home urine collection kit for STIsLehigh Valley Business·Jun 11, 2026
- OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted InfectionsYahoo Finance·Jun 11, 2026
- Is Co-Diagnostics National Security’s Next Diagnostic Pick?Marketbeat·May 28, 2026
- Cardiff Oncology And 2 Other Promising Penny Stocks For Your WatchlistYahoo Finance·May 20, 2026
- OraSure Technologies Independent Director Acquires 195% More StockYahoo Finance·May 17, 2026
- OraSure Technologies, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- OraSure Technologies Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- OraSure (OSUR) Q1 2026 Earnings TranscriptThe Motley Fool·May 6, 2026
- OraSure Announces First Quarter 2026 Financial ResultsYahoo Finance·May 6, 2026
- OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6thYahoo Finance·Apr 22, 2026
- OraSure Technologies Appoints John D. Bertrand to its Board of DirectorsGlobeNewswire Inc.·Apr 17, 2026
- Why OraSure Technologies (OSUR) Is Back in the Spotlight as Sale Pressure BuildsYahoo Finance·Apr 16, 2026
- Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor IntelligenceGlobeNewswire Inc.·Apr 3, 2026
- OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai CapitalYahoo Finance·Mar 17, 2026
- Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued UnderperformanceYahoo Finance·Mar 17, 2026
- OraSure Technologies, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 26, 2026
- OraSure Technologies Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights: Revenue Exceeds Expectations ...Yahoo Finance·Feb 26, 2026
- OraSure: Q4 Earnings SnapshotYahoo Finance·Feb 25, 2026
- OraSure Announces Fourth Quarter 2025 Financial ResultsYahoo Finance·Feb 25, 2026
- OraSure to Launch OraQuick™ HIV Self-Test in CanadaYahoo Finance·Feb 10, 2026
- OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25thYahoo Finance·Feb 9, 2026
All 22 articles loaded
Price Data
Open$4.12
Previous Close$4.24
Day High$4.29
Day Low$4.11
52 Week High$4.58
52 Week Low$2.08
52-Week Range
$2.08$4.58
$4.24
Fundamentals
Market Cap$286M
P/E Ratio—
EPS$-1.05
Dividend Yield—
Dividend / Share—
ROE-21.2%
Profit Margin-66.4%
Debt / Equity—
Trading
Volume564K
Avg Volume (10D)—
Shares Outstanding68.8M
About OraSure Technologies Inc
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—